Skip to main content
. 2015 Nov 6;10:1825–1837. doi: 10.2147/CIA.S93819

Figure 5.

Figure 5

ROS levels in the blood of the R6/2 (HD) mice were reduced under oral B401 treatment.

Notes: (A) Chemiluminescence analysis shows that the expressions of ROS in the blood of the 10-week-old R6/2 mice given the oral B401 treatment were obviously weaker than those given the sham treatment but were obviously more intense than their WT. (B) The quantified expression blood levels of ROS in the 10-week-old R6/2 mice given the oral B401 treatment were significantly lower than those mice given the sham treatment. The number of R6/2 mice under oral B401 and sham treatments was six for each group. Values are mean ± SEM (**P<0.01, one-way ANOVA followed by a Student–Newman–Keuls multiple comparison posttest).

Abbreviations: ECL, electro-chemiluminescence; HD, Huntington’s disease; ROS, reactive oxygen species; WT, wild-type littermate; ANOVA, analysis of variance; SEM, standard error of the mean.